Availability of Medication for Opioid Use Disorder Among Accountable Care Organizations: Evidence From a National Survey-Reference-Cited by-同舟云学术

Availability of Medication for Opioid Use Disorder Among Accountable Care Organizations: Evidence From a National Survey

Published:2024-02-01 Issue:2 Volume:75 Page:182-185
ISSN:1075-2730
Container-title:Psychiatric Services
language:en
Short-container-title:PS

Author:

Newton Helen¹,Miller-Rosales Chris¹,Crawford Maia¹,Cai Arno¹,Brunette Mary¹,Meara Ellen¹

Affiliation:

1. Department of Family Medicine, University of North Carolina School of Medicine, Chapel Hill (Newton); Department of Health Care Policy, Harvard Medical School, Boston (Miller-Rosales); Dartmouth Institute for Health Policy & Clinical Practice, Dartmouth Geisel School of Medicine, Lebanon, New Hampshire (Crawford); Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston (Cai, Meara); Department of Psychiatry, Dartmouth Geisel School of Medicine, Hanover, New...

Publisher

American Psychiatric Association Publishing

Subject

Psychiatry and Mental health

Reference13 articles.

1. What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? Using multiplier approaches to estimate prevalence for an unknown population size

2. Use of Medication for Opioid Use Disorder Among US Adolescents and Adults With Need for Opioid Treatment, 2019

3. In Rural Areas, Buprenorphine Waiver Adoption Since 2017 Driven By Nurse Practitioners And Physician Assistants

4. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic

5. Geographic Disparities in Availability of Opioid Use Disorder Treatment for Medicaid Enrollees